Mirabella Financial Services’s Akebia Therapeutics AKBA Stock Holding History

Mirabella Financial Services’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-65,300	Closed	-$81K	–	495
2023 Q4	$81K	Buy	+65,300	New	+$66.6K	0.01%	405
2023 Q2	–	Sell	-140,604	Closed	-$1.83M	–	478
2023 Q1	$1.83M	Buy	+140,604	New	+$107K	0.28%	77
2022 Q2	–	Sell	-56,300	Closed	-$40K	–	456
2022 Q1	$40K	Buy	+56,300	New	+$120K	﹤0.01%	497
2021 Q3	–	Sell	-267,603	Closed	-$1.01M	–	424
2021 Q2	$1.01M	Sell	267,603 -200,641	-43%	-$675K	0.18%	126
2021 Q1	$1.58M	Buy	+468,244	New	+$1.69M	0.49%	57

Other funds holding AKBA

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Mirabella Financial Services's AKBA Position: Q1 2024 in Review

Mirabella Financial Services sold out of Akebia Therapeutics (AKBA) in Q1 2024, closing a stake of 65,300 shares — an estimated $81K sold.

Mirabella Financial Services first reported a position in AKBA in Q1 2021 and held it in 5 quarters. The position peaked at $1.83M in Q1 2023. 114 funds tracked by Wall St. Rank hold AKBA as of Q1 2024.

Mirabella Financial Services reported no remaining Akebia Therapeutics position as of Q1 2024 after selling out during the quarter.
Mirabella Financial Services sold 65,300 Akebia Therapeutics shares in Q1 2024, an estimated $81K.
Mirabella Financial Services first reported a position in Akebia Therapeutics in Q1 2021 and held it in 5 quarters.
Mirabella Financial Services's Akebia Therapeutics position peaked at $1.83M in Q1 2023.
114 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2024.

Based on Mirabella Financial Services's 13F filing for Q1 2024, filed 15 May 2024.